Skip to main content
Log in

Prevention of haloperidol-induced alterations in brain acetylcholinesterase activity by vitamins B co-administration in a rodent model of tardive dyskinesia

  • Original Paper
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Tardive dyskinesia (TD) is an iatrogenic syndrome being a significant adverse outcome of typical and atypical antipsychotic therapy. Recently we demonstrated that vitamins B (B1, B6, B12 alone or in combination) were able to prevent haloperidol-induced orofacial dyskinesia (OD) possibly by their antioxidant activity in the striatum, using a well-established model of TD. Here, based on the fact that alterations in cholinergic neurotransmission are related to TD pathophysiology and that vitamins B seems to influence brain cholinergic neurotransmission, we decided to investigate the effects of vitamins B1, B6, B12 and their association, vitamin B cocktail in haloperidol-induced cholinergic alterations, evaluated by alterations in acetylcholinesterase (AChE) activity, in striatum, prefrontal cortex and hippocampus, as a way to determine the participation of cholinergic neurotransmission, in these vitamins antidyskinetic mechanism. Haloperidol 1 mg/kg i.p. daily administration during 21 days to Wistar rats caused OD while decreased AChE activity in all brain areas studied. Vitamins B administration (B1:B6:B12 at 60:60:0.6 mg/kg, s.c) alone and vitamin B cocktail co-administered with haloperidol prevented OD development and increased AChE activity in all brain areas studied, with the maximum activity increment observed in the hippocampus of the animals co-treated with vitamin B12 and vitamin B cocktail. The antidyskinetic drug, clozapine did not induce OD and increased AChE activity similarly to the groups coadministered with vitamin B and HAL. The present data suggest that vitamins B can prevent haloperidol-induced alterations in AChE activity what can be related to the mechanism underlying their antidyskinetic effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

ACh:

Acetylcholine

AChE:

Acetylcholinesterase

ChIs:

Cholinergic interneurons

DA:

Dopamine

HC:

Hippocampus

OD:

Orofacial dyskinesia

PFC:

Prefrontal cortex

ST:

Striatum

TD:

Tardive dyskinesia

TP:

Tongue protrusion

VCM:

Vacuous chewing movements

Vitamin B1:

Thiamine

Vitamin B6:

Pyridoxine

Vitamin B12:

Cyanocobalamin

References

  • Anzalone S, Vetreno RP, Ramos RL, Savage LM (2010) Cortical cholinergic abnormalities contribute to the amnesic state induced by pyrithiamine-induced thiamine deficiency in the rat. Eur J Neurosci 32(5):847–858. doi:10.1111/j.1460-9568.2010.07358.x

    Article  PubMed  Google Scholar 

  • Barak S, Weiner I (2007) Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. Neuropsychopharmacology 32(5):989–999. doi:10.1038/sj.npp.1301208

    Article  PubMed  CAS  Google Scholar 

  • Barnes TRE, Pantelis S, Collinson S, Nelson HE, Carruthers K, Halstead SM (1994) Relationship between tardive-dyskinesia, intellectual impairment and bradyphrenia in chronic-schizophrenic inpatient population. Schizophr Res 11(2):193–193

    Article  Google Scholar 

  • Bishnoi M, Chopra K, Kulkarni SK (2009) Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels. Pharmacol Biochem Behav 91(3):423–429. doi:10.1016/j.pbb.2008.08.021

    Article  PubMed  CAS  Google Scholar 

  • Bonsi P, Cuomo D, Martella G, Madeo G, Schirinzi T, Puglisi F, Ponterio G, Pisani A (2011) Centrality of striatal cholinergic transmission in Basal Ganglia function. Front Neuroanat 5:6. doi:10.3389/fnana.2011.00006

    Article  PubMed  Google Scholar 

  • Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A (2012) Prefrontal alterations in Parkinson’s disease with levodopa-induced dyskinesia during fMRI motor task. Mov Disord 27(3):364–371

    Article  PubMed  Google Scholar 

  • Ebadi M (1981) Regulation and function of pyridoxal phosphate in CNS. Neurochem Int 3(3–4):181–205

    Article  PubMed  CAS  Google Scholar 

  • Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95

    Article  PubMed  CAS  Google Scholar 

  • Friedman JI (2004) Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology 174(1):45–53

    Article  PubMed  CAS  Google Scholar 

  • Gibson GE, Zhang H (2002) Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration. Neurochem Int 40(6):493–504

    Article  PubMed  CAS  Google Scholar 

  • Grimm JW, Chapman MA, Zahm DS, See RE (2001) Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats. Synapse 39(1):51–57. doi:10.1002/1098-2396(20010101)39:1<51::aid-syn7>3.0.co;2-z

    Article  PubMed  CAS  Google Scholar 

  • Jeste DV, Lohr JB (1989) Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry 46(11):1019–1024

    Article  PubMed  CAS  Google Scholar 

  • Jeste DV, Lohr JB, Manley M (1992) Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats. Psychopharmacology 106(2):154–160. doi:10.1007/bf02801966

    Article  PubMed  CAS  Google Scholar 

  • Johnstone EC, Crow TJ, Ferrier IN, Frith CD, Owens DG, Bourne RC, Gamble SJ (1983) Adverse effects of anticholinergic medication on positive schizophrenic symptoms. Psychol Med 13(3):513–527

    Article  PubMed  CAS  Google Scholar 

  • Jones CK, Shannon HE (2000) Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. J Pharmacol Exp Ther 294(3):1017–1023

    PubMed  CAS  Google Scholar 

  • Jones CK, Eberle EL, Shaw DB, McKinzie DL, Shannon HE (2005) Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats. J Pharmacol Exp Ther 312(3):1055–1063

    Article  PubMed  CAS  Google Scholar 

  • Kane JM, Woerner M, Lieberman J (1988) Epidemiological aspects of tardive dyskinesia. Encephale 14(Spec No):191–194

    PubMed  Google Scholar 

  • Lerner V, Miodownik C, Kaptsan A, Bersudsky Y, Libov I, Sela BA, Witztum E (2007) Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. J Clin Psychiatry 68(11):1648–1654

    Article  PubMed  CAS  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275

    PubMed  CAS  Google Scholar 

  • Macedo DS, de Oliveira GV, Lima Gomes PX, Ramos de Araujo FY, de Souza CM, Mendes Vasconcelos SM, de Barros Viana GS, Florenco de Sousa FC, Carvalho AF (2011) B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms. Behav Pharmacol 22(7):674–680. doi:10.1097/FBP.0b013e32834aff6d

    Article  PubMed  CAS  Google Scholar 

  • Mahadik SP, Mukherjee S (1995) Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain. Biol Psychiatry 38(4):246–254. doi:10.1016/0006-3223(94)00304-l

    Article  PubMed  CAS  Google Scholar 

  • Mahadik SP, Laev H, Korenovsky A, Karpiak SE (1988) Haloperidol alters rat CNS cholinergic system—enzymatic and morphological analyses. Biol Psychiatry 24(2):199–217. doi:10.1016/0006-3223(88)90275-2

    Article  PubMed  CAS  Google Scholar 

  • Martella G, Tassone A, Sciamanna G, Platania P, Cuomo D, Viscomi MT, Bonsi P, Cacci E, Biagioni S, Usiello A, Bernardi G, Sharma N, Standaert DG, Pisani A (2009) Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 132(Pt 9):2336–2349. doi:10.1093/brain/awp194

    Article  PubMed  Google Scholar 

  • Miller R, Chouinard G (1993) Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biol Psychiatry 34(10):713–738

    Article  PubMed  CAS  Google Scholar 

  • Naidu PS, Singh A, Kulkarni SK (2003) Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 44(8):1100–1106

    Article  PubMed  CAS  Google Scholar 

  • Olianas MC, Maullu C, Onali P (1999) Mixed agonist–antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells. Neuropsychopharmacology 20(3):263–270. doi:10.1016/s0893-133x(98)00048-7

    Article  PubMed  CAS  Google Scholar 

  • Pereira RP, Fachinetto R, AdS P, Wagner C, Sudati JH, Boligon AA, Athayde ML, Morsch VM, Teixeira Rocha JB (2011) Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats. J Neural Transm 118(11):1547–1557. doi:10.1007/s00702-011-0640-7

    Article  PubMed  CAS  Google Scholar 

  • Pisani A, Bernardi G, Ding J, Surmeier DJ (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30(10):545–553. doi:10.1016/j.tins.2007.07.008

    Article  PubMed  CAS  Google Scholar 

  • Raja M (2011) Clozapine safety, 35 years later. Curr Drug Saf 6(3):164–184

    Article  PubMed  CAS  Google Scholar 

  • Sasaki H, Matsuzaki Y, Meguro K, Ikarashi Y, Maruyama Y, Yamaguchi S, Sekizawa K (1992) Vitamin B12 improves cognitive disturbance in rodents fed a choline-deficient diet. Pharmacol Biochem Behav 43(2):635–639

    Article  PubMed  CAS  Google Scholar 

  • Tamminga CA, Woerner MG (2002) Clinical course and cellular pathology of tardive dyskinesia. In: Davies KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacoly: The fifth generation of progress. American College of Neuropsychopharmacology, pp 1831–1841

  • Tandon R (1999) Cholinergic aspects of schizophrenia. Br J Psychiatry Suppl 37:7–11

    PubMed  Google Scholar 

  • Thomas TM, Smith Y, Levey AI, Hersch SM (2000) Cortical inputs to m2-immunoreactive striatal interneurons in rat and monkey. Synapse 37(4):252–261. doi:10.1002/1098-2396(20000915)37:4<252::AID-SYN2>3.0.CO;2-A

    Article  PubMed  CAS  Google Scholar 

  • Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM (2010) Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. J Clin Psychiatry 71(4):463–474. doi:10.4088/JCP.07m03890yel

    Article  PubMed  CAS  Google Scholar 

  • Yan Z, Surmeier DJ (1997) D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade. Neuron 19(5):1115–1126

    Article  PubMed  CAS  Google Scholar 

  • Yan Z, Song WJ, Surmeier J (1997) D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J Neurophysiol 77(2):1003–1015

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Danielle Silveira Macêdo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Oliveira, G.V., Gomes, P.X.L., de Araújo, F.Y.R. et al. Prevention of haloperidol-induced alterations in brain acetylcholinesterase activity by vitamins B co-administration in a rodent model of tardive dyskinesia. Metab Brain Dis 28, 53–59 (2013). https://doi.org/10.1007/s11011-012-9345-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-012-9345-3

Keywords

Navigation